Preventing HIV Breakthrough and Rebuilding Immune Function
Keynote Address
- Immunity to HIV-Does it Matter?
Bruce D. Walker, MD
Causes and Consequences of Virologic Failure
- Latent Reservoirs for HIV -1: Implications For Virus Eradication
Robert Siliciano, MD, PhD - HIV Therapy: Dynamics, Resistance and Reservoirs
Doug Richman, MD - Targeting Cellular Factors: An Alternative to Control HIV Rebound and Rebuild Immune Function
Franco Lori, MD - Behavior and Breakthrough
Frederick M. Hecht, MD
Breakout Sessions
- Is Eradication Possible?
- Immune Preservation after Virologic Failure
- Extending Therapy To Developing Countries
Rebuilding Immune Function
- Prevalence of Antiviral Medication Use in a Probability Sample of HIV Seropositive MSMs in Major U.S. Cities
Ronald D. Stall, PhD, MPH - Prevalence of Viral Drug Resistance
Robert M. Grant, MD, MPH, MS - Predicting and Preventing the Emergence of Antiretroviral Drug Resistance in San Francisco
Sally Blower, PhD - Viral and Cellular Dynamics in HIV Infected Lymphoid Tissue
R. Pat Bucy, MD, PhD - Monitoring of Thymic Dependent T-Cell Regeneration
Crystal Mackall, MD - T-Cell Production in HIV-1 Disease
Joseph M. McCune, MD, PhD